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Summary 
Polyelectrolyte surface–modified Cowpea mosaic virus (CPMV) can be used for the 
templated synthesis of narrowly dispersed gold nanoparticles. Cationic 
polyelectrolyte, poly(allylamine) hydrochloride, is electrostatically bound to the 
external surface of the virus capsid. The polyelectrolyte–coated CPMV promotes 
adsorption of aqueous gold hydroxide anionic species, prepared from gold(III) 
chloride and potassium carbonate, that are easily reduced to form CPMV–templated 
gold nanoparticles. The process is simple and environmentally benign using only 
water as solvent at ambient temperature. 
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 1. Introduction 
Gold nanoparticles have recently generated considerable interest because of their 
potential for applications in the optical sensing of biological and chemical analytes 
(1), diagnostics, drug delivery and photothermal therapy (2). Particles of the 30 nm 
diameter icosahedral plant virus, Cowpea mosaic virus (CPMV), provide an ideal 
nanotemplate for mineralization. The genetic, biological and physical properties of the 
virus are well characterised and its structure is known to near atomic resolution (3). 
Groups on the exterior surface of the virus capsid enable the attachment of many 
different chemicals and make CPMV a useful nanoscaffold (4–7). Over the past few 
years we have investigated methods for the synthesis of CPMV–templated, inorganic, 
monodisperse, nanoparticles. The approaches include: (i) using genetically modified 
CPMV chimaeras that display peptides on their outer surface which promote specific 
mineralization processes, to create silica (8) and iron–platinum (9) nanoparticles; (ii) 
chemically–coupled–peptide–promoted mineralization of wild–type CPMV, for iron–
platinum, cobalt–platinum and zinc sulfide (10); (iii) an electroless deposition 
technique, for iron, cobalt, nickel, platinum, cobalt–platinum and nickel–iron (11); 
(iv) templated mineralization by charge–modified CPMV, for cobalt and iron oxide 
(12), see Chapter X.  
 
Here, we describe the use of polyelectrolyte–modified CPMV for the synthesis of 
gold nanoparticles (Fig. 1) (13). CPMV at neutral pH can be considered as an anionic 
macromolecule with an isoelectric point (pI) of 4.3 ± 0.1 (14). At physiological pH 
(pH 7.4), aspartic and glutamic acid residues on the external surface of the virus 
capsid are deprotonated so the surface presents an overall negative charge. Incubation 
of CPMV with cationic polyelectrolyte, poly(allylamine) hydrochloride (PAH), led to 
electrostatic adsorption of a thin layer of polyelectrolyte onto the capsid surface, 
PACPMV. The PACPMV was characterised by a range of techniques (13) including 
uranyl acetate stained transmission electron microscopy (TEM) (Fig. 2). An aqueous 
gold hydroxide solution was prepared from gold(III) chloride and potassium 
carbonate (Equations) by a published procedure (15, 16). Treatment of PACPMV with 
this solution initially electrostatically adsorbs anionic gold(III) hydroxyl species onto 
the cationic surface of the PACPMV particles. Mild reduction gave metallic gold at the 
surface; the reaction was accompanied by a colour change from colourless to light 
purple. After purification, the gold coated CPMV nanoparticles (Au–CPMV) were 
characterised by a range of techniques (13) including TEM (Fig. 2), dynamic light 
scattering (DLS), energy dispersive X–ray spectroscopy and zeta potential 
measurements. 
 
K2CO3 + 2H2O → H2CO3 + 2KOH 
HCO3
–  + HAuCl4 → [AuCl4]– + H2CO3  
[AuCl4]
– + xOH–  → Au(OH)xCly– (x + y = 4) + (4–y)Cl–   Equations 
 
“[Fig 1 near here]” 
 
The Au–CPMV particle size, as measured by DLS, showed an average diameter of ca. 
67 nm; the gold coating has a thickness of approximately 20 nm. The particles were 
narrowly dispersed, in agreement with the observed TEM images, and the CPMV 
particles were mineralized on their outer surfaces. The thickness of the gold coating 
can be controlled. For example, by reducing the volume of the gold solution aliquot 
by half gave particles of ca. 40 nm diameter, whereas doubling the gold solution 
aliquot gave larger particles of ca. 300 nm diameter, when all other conditions were 
kept constant. The method is simple and environmentally benign, as only aqueous 
solvent and ambient temperature and pressure are required. 
 
“[Fig 2 near here]” 
 
2. Materials 
Poly(allylamine hydrochloride) (PAH, MW ~15000), poly(fluorescein isothiocyanate 
allylamine hydrochloride) (FITC–PAH, MW ~9291) were purchased from Sigma–
Aldrich; potassium carbonate from BDH; hydroxylamine hydrochloride, 99 %, from 
Lancaster Synthesis; Sephadex G–25 PD–10 columns from GE Healthcare; 100 and 
300 kDa  molecular weight cut–off membranes from Spectrum Labs. All reagents 
were used without further purification and all experiments were performed using 
Milli–Q water with resistivity of 18.2 MΩ cm (Millipore). The propagation and 
purification of wild–type CPMV particles were performed by standard procedures 
(17). Purified virions were stored at 4 ºC in 10 mM sodium phosphate buffer pH 7.0. 
(1 litre of 0.2 M Na2HPO4 (27.0 g) and 1 litre of 0.2 M NaH2PO4 (28.39 g) were 
prepared in Milli–Q water and autoclaved before mixing. To prepare 0.1 M buffer 
solution; 305 mL of Na2HPO4 solution and 195 mL of NaH2PO4 solution was added 
to 500 mL Milli–Q water that gave a pH of 7.0). 
 
3. Methods 
Poly(allylamine)hydrochloride-CPMV (PACPMV) 
1.  Before and after each experimental step UV–visible absorbance was 
recorded at 260 nm (see Note 1). 
2. Just prior to use, CPMV particles were suspended in Milli–Q water by 
either buffer exchange on disposable gel filtration columns (PD–10) 
pre–equilibrated with Milli–Q water or by dialysis using 100 kDa cut–
off membranes for 4–6 hours, changing Milli–Q water at 2 hourly 
intervals. Typically 10 mg mL–1 CPMV particles were suspended in 
2.5 mL; the void volume of the gel filtration column. 
3. CPMV particles suspended in Milli–Q water (1 mg mL–1, 1 mL) were 
added dropwise over 5–10 minutes, with continuous and vigorous 
stirring on a vortex mixer at 2000 rpm, to a freshly prepared solution of 
polyallylamine hydrochloride (PAH) (1 mg mL–1) dissolved in aqueous 
0.25 M NaCl (1 mL).  
4. The cationic polyelectrolyte was allowed to adsorb onto the virus 
capsid for 30 minutes while gently shaking (800 rpm) at 4 °C (cold 
room).  
5. The PACPMV particles were washed 3–4 times with Milli–Q water (15 
mL) on 100 or 300 kDa cut–off membranes. 
6. Quality control: to ensure modified–virus particle integrity before 
proceeding to the next step, PACPMV particles were run on an agarose 
electrophoresis gel and stained with ethidium bromide or Coomassie 
blue (see Note 2). 
 
“[Fig 3 near here]” 
7. The washing was followed by dialysis against 10 mM sodium 
phosphate buffer pH 7.0 for 3 hours at ambient temperature or in the 
cold room (4 °C). 
8. PACPMV was obtained in approximately 50% yield, based on initial 
virus concentration, as calculated by measuring the UV–visible 
absorbance at 260 nm.  
 
Gold hydroxide solution 
1. Gold(III) chloride trihydrate (17.4 mL of 25 mM solution) was diluted with 
Milli–Q water (982.6 mL) in a 1 litre brown Duran bottle. 
2. Potassium carbonate (249 mg, 1.8 mM) was added to the solution. 
3. The solution was aged for 1–2 days in the dark (in brown foil wrapped vial) 
at 4 °C, during which it changed colour from yellow to colourless due to the 
formation of gold hydroxide solution (15, 16). 
4. Gold hydroxide solution was used within 2 weeks 
 
Gold coated CPMV nanoparticles (Au–CPMV)  
1. Freshly prepared PACPMV particles (1–1.5 mg mL–1, 1mL) suspended in 
Milli–Q water were incubated with gold hydroxide solution (1 mL) as 
prepared above. The thickness of the gold coating was controlled by varying 
the incubation time with the gold hydroxide solution (see Note 3).  
2. The reaction solution, in a vial wrapped in foil, was left stirring at 600 rpm 
at ambient temperature for 2 hours. 
3. A freshly prepared aqueous solution of hydroxylamine hydrochloride was 
added to a final concentration of 20 mM.  
4. The reduction reaction was left to proceed for a further 20 minutes at 
ambient temperature. 
5. Au–CPMV particles were spun at 14000 rpm (bench top centrifuge) for 20 
minutes to remove any large aggregates. 
6. The supernatant was collected and layered onto 5 mL 10%–50% sucrose 
gradients (see Note 4). Sucrose fractions containing Au–CPMV particles 
(bluish colour) were collected and dialysed against 10 mM sodium 
phosphate buffer pH 7.0 for 15 hours using 100 kDa molecular weight cut–
off membranes. 
 
4. Notes  
1. UV–visible spectroscopy of CPMV particles: Virus concentration was determined 
by photometrical measurement using either a Perkin Elmer Lambda 25 UV–VIS 
spectrophotometer with UVWINLab Software or a NanoDrop® ND–1000 
spectrophotometer and ND–1000 software, at room temperature using a quartz 
cuvette (light path 1 cm). CPMV particles have an absorption maximum at a 
wavelength of λ = 260 nm (derived from the encapsidated RNA molecules) with 
molar extinction coefficient of ε = 8.1 mL mg–1 cm–1. The law of Beer–Lambert can 
be used to calculate the concentration: 
 
A = c d ε 
 Where A is the absorbance, c is the concentration of the particles in mg mL–1, d is the 
length of the light path in cm and ε the molar extinction coefficient in mL mg–1 cm–1. 
2. Confirmation of adsorption of polyelectrolyte to the surface was by the use of 
fluorescently labelled polyelectrolyte, poly(fluorescein isothiocyanate allylamine 
hydrochloride (FITC-PA). FITC–PACPMV particles were prepared following the same 
method as described for PACPMV except that the incubation was for 15 minutes.  
3. Treatment of PACPMV under our standard conditions, as described, gave a particle 
size of ca. 67 nm. Keeping all other conditions the same but reducing the volume of 
the gold solution aliquot by half gave particles of ca. 40 nm diameter, whereas 
doubling the gold solution aliquot gave much larger particles of ca. 300 nm diameter.  
4. Sucrose Gradients: Sucrose solutions of 50%, 40%, 30%, 20%, and 10% (w/v) in 
10 mM sodium phosphate buffer pH 7.4 were prepared and used within 2 weeks. 
Gradients were prepared by underlying sucrose solutions of decreasing density (175 
or 500 µL) in a centrifuge tube of (2.1 mL or 5 mL, respectively) and carefully 
overlaying the sample to fill the tube. Gradients were ultracentrifuged in a swing–out 
rotor (AH–650) and centrifuged at 137000 g for 1.5–2.5 hours at 4 ºC; 175–300 μL 
fractions containing modified particles were collected and buffer exchanged for 10 
mM sodium phosphate buffer pH 7.4.  
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Figure Legends:  
Figure 1. Schematic representation of polyelectrolyte surface–modified CPMV 
templated synthesis of gold nanoparticles (Reprinted with permission from 
Biomacromolecules, 2011, 12, 2723-2728. Copyright 2011 American Chemical 
Society). 
Figure 2. TEM images of (A) uranyl acetate stained PACPMV and (B) unstained Au–
CPMV with high magnification image shown in inset (Reprinted with permission 
from Biomacromolecules, 2011, 12, 2723-2728. Copyright 2011 American Chemical 
Society). 
Figure 3. Agarose gel electrophoresis (1.2%). (A) unstained, (B) ethidium bromide 
stained and (C) Coomassie blue stained. Lane 1, CPMVwt, Lane 2, PACPMV and 
Lane 3, FITC–PACPMV (see Note 2). Gel C is a photographic image at different scale to 
A and B (Reprinted with permission from Biomacromolecules, 2011, 12, 2723-2728. 
Copyright 2011 American Chemical Society). 
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